Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Nasus Pharma Ltd.
NSRX · SEC Filings
website
7
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of i...
Price
2.935
Market Cap
34.44 M
Float
6.56 M
Country
IL
Sector
Healthcare
Exchange
AMEX
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about NSRX
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Nasus Pharma Ltd.
NSRX · SEC Filings
6.56 M
Float
2.935
Price
34.44 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 25, 2026
News
TYPE
HEADLINE
FILED AT
Prospectus
TYPE
HEADLINE
FILED AT
424B5
September 2026 ATM | Offering amount: $8,500,000 | Bank: BTIG, LLC
Sep 18, 2026
424B4
SHARE RESALE REGISTRATION | Shares amount: 1,250,000 | Share price: $8 | | Offering amount: $10,000,000
Aug 14, 2025
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 19, 2026
F-3
September 2026 SHELF
Sep 1, 2026
POS AM
SHARE RESALE REGISTRATION | Shares: 5,121,308 EFFECTIVE, DATED 2026-08-20
Aug 18, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
May 26, 2026
POS AM
Form POS AM - Post-Effective amendments for registration statement
Mar 27, 2026
F-1
SHARE RESALE REGISTRATION
Mar 2, 2026
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
3
Elmaliah Oren (Reporting)
Sep 23, 2026
4
Rubin Eyal (Reporting)
Sep 21, 2026
SCHEDULE 13G/A
BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Aug 14, 2026
3
O'Grady Brendan P. (Reporting)
Jul 31, 2026
4
Teleman Dan Benjamin (Reporting)
Jul 29, 2026
4
Teleman Dan Benjamin (Reporting)
Jun 22, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
